Mike Flores, MD, MBA, Global Head CDx Pathology, Roche & Ying Kong, MD, PhD, Medical Affairs Leader, Roche
Immunohistochemistry assessment of PD-L1 protein expression levels in the tumor microenvironment is critical for identifying patients eligible for imm...